Aspen Pharmacare Holdings Statistics

Total Valuation

Aspen Pharmacare Holdings has a market cap or net worth of ZAR 85.48 billion. The enterprise value is 109.60 billion.

Market Cap	85.48B
Enterprise Value	109.60B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	Sep 18, 2024

Share Statistics

Aspen Pharmacare Holdings has 444.95 million shares outstanding.

Shares Outstanding	444.95M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	17.15%
Owned by Institutions (%)	46.78%
Float	278.90M

Valuation Ratios

The trailing PE ratio is 19.38 and the forward PE ratio is 10.75.

PE Ratio	19.38
Forward PE	10.75
PS Ratio	1.91
PB Ratio	1.01
P/FCF Ratio	27.50
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.22, with an EV/FCF ratio of 35.26.

EV / Earnings	24.89
EV / Sales	2.45
EV / EBITDA	12.22
EV / EBIT	15.66
EV / FCF	35.26

Financial Position

The company has a current ratio of 1.81, with a Debt / Equity ratio of 42.96.

Current Ratio	1.81
Quick Ratio	1.07
Debt / Equity	42.96
Debt / EBITDA	4.06
Debt / FCF	11.73
Interest Coverage	3.07

Financial Efficiency

Return on equity (ROE) is 5.15% and return on invested capital (ROIC) is 3.69%.

Return on Equity (ROE)	5.15%
Return on Assets (ROA)	3.20%
Return on Capital (ROIC)	3.69%
Revenue Per Employee	5.03M
Profits Per Employee	495,555
Employee Count	9,161
Asset Turnover	0.33
Inventory Turnover	1.34

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.40% in the last 52 weeks. The beta is 0.69, so Aspen Pharmacare Holdings's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	+16.40%
50-Day Moving Average	22,937.78
200-Day Moving Average	21,528.84
Relative Strength Index (RSI)	23.46
Average Volume (20 Days)	1,595,501

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aspen Pharmacare Holdings had revenue of ZAR 44.71 billion and earned 4.40 billion in profits. Earnings per share was 9.91.

Revenue	44.71B
Gross Profit	19.45B
Operating Income	7.00B
Pretax Income	5.71B
Net Income	4.40B
EBITDA	8.97B
EBIT	7.00B
Earnings Per Share (EPS)	9.91

Full Income Statement

Balance Sheet

The company has 12.34 billion in cash and 36.46 billion in debt, giving a net cash position of -24.12 billion or -54.20 per share.

Cash & Cash Equivalents	12.34B
Total Debt	36.46B
Net Cash	-24.12B
Net Cash Per Share	-54.20
Equity (Book Value)	84.86B
Book Value Per Share	191.09
Working Capital	19.71B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.23 billion and capital expenditures -3.12 billion, giving a free cash flow of 3.11 billion.

Operating Cash Flow	6.23B
Capital Expenditures	-3.12B
Free Cash Flow	3.11B
FCF Per Share	6.99

Full Cash Flow Statement

Margins

Gross margin is 43.52%, with operating and profit margins of 15.65% and 9.85%.

Gross Margin	43.52%
Operating Margin	15.65%
Pretax Margin	12.78%
Profit Margin	9.85%
EBITDA Margin	20.07%
EBIT Margin	15.65%
FCF Margin	6.95%

Dividends & Yields

This stock pays an annual dividend of 3.59, which amounts to a dividend yield of 1.87%.

Dividend Per Share	3.59
Dividend Yield	1.87%
Dividend Growth (YoY)	4.91%
Years of Dividend Growth	2
Payout Ratio	34.63%
Buyback Yield	n/a
Shareholder Yield	1.87%
Earnings Yield	5.16%
FCF Yield	3.64%

Dividend Details

Stock Splits

The last stock split was on October 6, 2008. It was a forward split with a ratio of 1.0175.

Last Split Date	Oct 6, 2008
Split Type	Forward
Split Ratio	1.0175